InFocus: Life Sciences & Healthcare e-newsletter - February 2007

In this issue we discuss:

• The new DOH/ABPI model clinical trials agreement
• The growing debate on patentability of human embryonic stem cells in Europe
• A recent UK repackaging case looking at consent and CE marking
• The Gower's Review and the changes it recommends to patent law and practice
• The new paediatric medicines legislation
• Implications of WEEE and REACH
• An update on the progress of the Advanced Therapies Regulation
• The future of patent litigation in Europe

About Taylor Wessing's Life Sciences & Healthcare Group

Taylor Wessing's market-leading Life Sciences & Healthcare Group provides a top quality, multi-disciplinary service.  The Group combines Taylor Wessing’s top-rated intellectual property and venture capital lawyers with specialists from our highly acclaimed international corporate, corporate finance, employment and real estate practices.  We advise life sciences and healthcare businesses, those who fund them and those who work for them.

For more information about Taylor Wessing's Life Sciences & Healthcare Group, please click here.

For any legal enquiries, please contact Daniel Pavin or your usual contact at Taylor Wessing.  For any marketing and business development enquiries, please contact Sharon Philbey.